AzTrials
AzTrials

Essential TremorUNMETNCT06610877

Ultrasound Neuromodulation in Essential Tremor

A study testing Focused ultrasound neuromodulation in people with Essential Tremor and Neuromodulation, run by University of California, San Francisco at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study is being done to test whether low-intensity focused ultrasound (LIFU) (low energy sound waves) cause temporary changes in brain activity and behavior when directed at particular parts of the brain. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Essential Tremor, Neuromodulation
What is being tested?
Focused ultrasound neuromodulation
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
60 participants
Where
1 siteUnited States
Study dates
1 Oct 2024to Mar 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients with medically refractory tremor scheduled to undergo MR-guided high-intensity focused ultrasound (HIFU) thalamotomy to treat their tremor at UCSF.

Who cannot join

  • Due to the logistical complexity of performing MRI in patients with MR-conditional pacemakers (need for device and patient monitoring), patients with pacemakers will be excluded from enrollment. All other patients undergoing HIFU thalamotomy for tremor will be eligible for enrollment.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Leo P. Sugrue, MD, PhD contact

415-353-9056

leo.sugrue@ucsf.edu

Tommaso Di Ianni, PhD contact

tommaso.diianni@ucsf.edu

United States1 site, 1 recruiting
  • Pritzker Building, UCSF

    San Francisco, California, 94107

    Leo P. Sugrue, MD PhD, leo.sugrue@ucsf.edu

    Tommaso Di Ianni, MD, tommaso.diianni@ucsf.edu

    Recruiting

Other trials in United States

About this study

This study is being done to test whether low-intensity focused ultrasound (LIFU) (low energy sound waves) cause temporary changes in brain activity and behavior when directed at particular parts of the brain. By targeting LIFU to the parts of the brain thought to be responsible for essential tremor (ET), and measuring any associated improvement in tremor, the investigators hope to show that LIFU can be a useful tool for studying the brain circuits responsible for tremor and other brain disorders.

Read the detailed description

Hypothesis

Precisely targeted low-intensity focused ultrasound (LIFU) modulation of the dentatorubrothalamic tract (DRTT) results in transient improvement of essential tremor (ET). DRTT LIFU neuromodulation produces functional connectivity changes that mirror brain network changes after MR-guided high-intensity focused ultrasound (HIFU) thalamotomy.

Aims

  1. To determine the optimal stimulation parameters for DRTT LIFU neuromodulation: the investigators will record wrist accelerometer signals while systematically varying pulse repetition frequency, duty cycle, and acoustic intensity.
  2. To map network effects of DRTT LIFU neuromodulation: the investigators will record resting state fMRI (rs-fMRI) immediately after DRTT LIFU neuromodulation with the parameters most effective at reducing tremor in each patient.

Design

This is a within-subject repeated-measures interventional study designed to determine the set of LIFU stimulation parameters that are maximally effective at producing a temporary tremor reduction when applied to the DRTT - the white matter circuit in the brain in which abnormal activity causes essential tremor.

The investigators will recruit patients from the established MR-guided high-intensity focused ultrasound (HIFU) ET program at UCSF (which treats 6-9 patients/month). Due to the logistical complexity of performing MRI in patients with MR-conditional pacemakers (need for device and patient monitoring), patients with pacemakers will be excluded from enrollment. Study inclusion criteria will otherwise be similar to those for the HIFU procedure itself, namely medically refractory tremor that is expected to improve with HIFU thalamotomy without contraindications to MRI or inability to stop anticoagulation. As part of their routine pre-procedure evaluation these patients receive a dedicated head CT for calculation of skull density ratio (SDR) and a 3T brain MRI that includes high resolution diffusion imaging for tractography to identify the DRTT, as well as specialized anatomic scans (including proton density (PD) and white matter nulled T1 (wm-null T1) sequences to define adjacent thalamic anatomy.

Study participants will undergo a single LIFU session lasting 3-4 hours, generally in the 1-2 days prior to their HIFU treatment. The investigators will perform LIFU stimulation using a commercially available, portable, neuronavigated focused ultrasound system (NeuroFUS PRO, BrainBox, Cardiff, UK) and will target LIFU stimulation using the same image-guided protocol used for the patient's subsequent HIFU treatment. Wrist-based accelerometers (MP160 + TSD109A; BIOPAC Systems, Inc.) will be used to provide a quantitative behavioral readout of the LIFU effect. The investigators will use power spectrum density analysis of accelerometer signals to quantify the severity of tremor before and after LIFU and HIFU sonications. To evaluate the effect of DRTT LIFU on tremor severity and the contribution of the different acoustic parameters tested, the investigators will perform individual- and group-level statistical analyses on the quantified tremor power in the characteristic ET range of 4-12 Hz. The hair on the participant's head will be shave at the start of the session to facilitate the passage of the ultrasound energy (an existing requirement of the subsequent HIFU treatment).

The transient nature of LIFU tremor reduction (on the order of 10-20 minutes) will facilitate high-throughput parameter screening through repeated sonications within the same session (up to 25, depending on patient response). Stimulation protocols consisting of 5 seconds of active stimulation followed by 10 seconds of no stimulation repeated four times (total 60 s) will be delivered using a range of sample parameters. Stimulation parameters will be shuffled in each session to control for carryover effects at the group level. After each 60-s stimulation, there will be a 3 minute inter-stimulation period, during which tremor severity will be monitored every 60 seconds through quantitative accelerometer recordings. If a change in tremor severity greater than 50% is found in the post-LIFU period compared to the pre-LIFU baseline, the investigators will wait until tremor returns to a level comparable to baseline before proceeding with additional stimulations. The entire LIFU stimulation session will last approximately 100 minutes, sufficient to screen up to 25 stimulation protocols (1 min sonication + 3 min wait per protocol) depending on tremor response.

At the end of the session, the investigators will identify the stimulation parameters that produced the largest tremor suppression compared to the respective pre-LIFU baseline. They will then deliver a sham (off-target or defocused) sonication using these maximally effective parameters to control for nonspecific sensory and auditory effects evoked by the ultrasound stimulation. Following this, the investigators will perform a final active sonication targeting the DRTT with the maximally effective parameters, this final stimulation will be immediately followed by a brief (~20-30 minute) MRI scan to measure the effects of LIFU on brain functional connectivity derived from rs-fMRI.

Patients will then proceed with their scheduled HIFU treatment, which will include similar intra-procedure wrist-base accelerometer measurements to document behavioral effects of HIFU on ET, as well as post treatment MRI to evaluate for post-treatment complications and to measure the effects of HIFU on brain functional connectivity as assessed with rs-fMRI.

Being tested
Focused Ultrasound Neuromodulation - Sham Control, Focused ultrasound neuromodulation
Keywords
Essential Tremor, Neuromodulation, Focused Ultrasound, brain functional connectivity
Medical subject headings
Essential Tremor

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Focused Ultrasound Neuromodulation - Sham ControlDevice

    Each ultrasound stimulation protocol will last for 60 seconds, consisting of 4 pulse trains of 5 seconds duration separated by 10 second intervals without stimulation. Across successive stimulation protocols (up to 25/patient) investigators will systematically vary pulse repetition frequency, duty cycle, and acoustic intensity to determine how these parameters contribute to the behavioral effect (transient tremor reduction). Parameters will be shuffled to control for group-level carry over effects. A defocusing lens will be in place during the session to test the difference between focused and unfoucused ultrasound while controlling for non-specific auditory and somatosensory confounds.

  • Focused ultrasound neuromodulationDevice

    Each ultrasound stimulation protocol will last for 60 seconds, consisting of 4 pulse trains of 5 seconds duration separated by 10 second intervals without stimulation. Across successive stimulation protocols (up to 25/patient) investigators will systematically vary pulse repetition frequency, duty cycle, and acoustic intensity to determine how these parameters contribute to the behavioral effect (transient tremor reduction) in each patient. Parameters will be shuffled to control for group-level carry over effects and will include sham (unfocused or off-target stimulation) conditions to control for non-specific auditory confounds.

Study groups in NCT06610877
Study groupRoleWhat they receive
To determine the most effective stimulation parameters for DRTT LIFU neuromodulation.ExperimentalInvestigators will record wrist accelerometer signals while participants maintain standardized postures that maximally elicit their tremor before, during, and after delivering LIFU stimulation.
Receives: Device: Focused Ultrasound Neuromodulation - Sham Control; Device: Focused ultrasound neuromodulation
Defocusing lensSham comparatorThis arm will be exactly the same as that of the active arm with the exception that a defocusing lens will be fitted to the ultrasound device which will cause the ultrasound energy to be dispersed rather than directed at the target structure.
Receives: Device: Focused Ultrasound Neuromodulation - Sham Control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Reduction in tremor

    The investigators will screen ultrasound parameters through repeated sonications within the same session (up to 25, depending on patient response) to determine which parameter set is most effective at reducing tremor in each participant as measured by wrist accelerometers (reduction in tremor power from baseline in the characteristic ET range of 4-12 Hz). Stimulation protocols will consist of 5 seconds of active stimulation followed by 10 seconds of no stimulation repeated four times (total 60 s). After each 60-s stimulation, there will be a delay of 3 minutes, during which the investigators will monitor tremor severity every 60 seconds through quantitative accelerometer recordings. If a change in tremor severity greater than 50% is found in the post-LIFU period compared to the pre-LIFU baseline, the investigators will wait until tremor returns to a level comparable to baseline before proceeding with additional stimulations.

    Measured: For 3 minutes immediately after the application of each sonication protocol

Secondary outcomes (1)
  1. Increases or decreases in functional connectivity of brain networks

    The investigators will record resting state fMRI (rs-fMRI) immediately after DRTT LIFU neuromodulation with the parameters most effective at reducing tremor in each patient. The investigators hypothesize that LIFU neuromodulation will result in systematic changes in functional connectivity in motor-related brain networks between pre-LIFU (baseline) imaging and immediate post-LIFU imaging. These changes will additionally be compared to those observed between baseline imaging and post-HIFU imaging.

    Measured: 20-30 minute MRI scan at the end of the 3-4 hour experimental session

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Sep 2024
  2. Study start1 Oct 2024
  3. Primary completionMar 2027 (estimated)
  4. Study completionMar 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Single group
Model description
This is a within-subject repeated-measures interventional study to test which of a set of LIFU stimulation parameters are most effective at producing temporary tremor reduction when applied to the DRTT - the white matter circuit involved in essential tremor. During a single session up to 25 different stimulation protocols will be tested in each participant in a shuffled manner including sham stimulation protocols.
Masking
Single blind
Who is masked
Participant
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06610877
Sponsor's protocol ID
P0573974
Acronym
UNMET
Status last verified
Mar 2026
First submitted
20 Sep 2024
Last updated
6 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Focused ultrasound neuromodulation in people with Essential Tremor and Neuromodulation, run by University of California, San Francisco at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 6 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Leo P. Sugrue, MD, PhD (415-353-9056, leo.sugrue@ucsf.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Reduction in tremor (time frame: For 3 minutes immediately after the application of each sonication protocol). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in